These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12600967)

  • 41. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
    Hattori N; Ishihara T; Saiki Y; Shimatsu A
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macroprolactin-a cause of pseudohyperprolactinaemia.
    Yuen YP; Lai JP; Au KM; Chan AY; Mak TW
    Hong Kong Med J; 2003 Apr; 9(2):119-21. PubMed ID: 12668823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of molecular variants of prolactin in human serum, evaluation of a method based on ultrafiltration.
    Landberg E; Wahlberg J; Rydén I; Arvidsson BM; Ekman B
    Clin Chim Acta; 2007 Feb; 376(1-2):220-5. PubMed ID: 17027953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia.
    Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
    Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical and laboratory aspects of the phenomenon of macroprolactinemia].
    Mel'nichenko GA; Goncharov NP; Dzeranova LK; Barmina II
    Vestn Ross Akad Med Nauk; 2007; (3):52-4. PubMed ID: 17500216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
    Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
    Clin Lab; 2007; 53(7-8):485-92. PubMed ID: 17821956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact on clinical practice of routine screening for macroprolactin.
    Gibney J; Smith TP; McKenna TJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3927-32. PubMed ID: 15811931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of macroprolactin detected by Elecsys 2010.
    Sánchez-Eixerés MR; Mauri M; Alfayate R; Graells ML; Miralles C; López A; Picó A
    Horm Res; 2001; 56(3-4):87-92. PubMed ID: 11847468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A high pressure liquid chromatography method for separation of prolactin forms.
    Bell DA; Hoad K; Leong L; Bakar JA; Sheehan P; Vasikaran SD
    Ann Clin Biochem; 2012 May; 49(Pt 3):285-8. PubMed ID: 22492879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia.
    Smith TP; Kelly S; Fahie-Wilson MN
    Clin Chem Lab Med; 2022 Aug; 60(9):1365-1372. PubMed ID: 35708266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.